Familial Amyloid Polyneuropathy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BBIO | F | BridgeBio Pharma, Inc. | -0.32 | |
IONS | F | Ionis Pharmaceuticals, Inc. | -1.88 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Familial Amyloid Polyneuropathy stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 4.43 | |
BBP | D | BioShares Biotechnology Products Fund | 3.24 | |
HELX | D | Franklin Genomic Advancements ETF | 3.03 | |
WDNA | D | WisdomTree BioRevolution Fund | 2.97 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 2.67 |
Compare ETFs
Related Industries:
Biotechnology
- Familial Amyloid Polyneuropathy
Familial amyloid polyneuropathy (FAP), also called transthyretin-related hereditary amyloidosis, transthyretin amyloidosis abbreviated also as ATTR (hereditary form), or Corino de Andrade's disease, is an autosomal dominant neurodegenerative disease. It is a form of amyloidosis, and was first identified and described by Portuguese neurologist Mário Corino da Costa Andrade, in 1952. FAP is distinct from senile systemic amyloidosis (SSA), which is not inherited, and which was determined to be the primary cause of death for 70% of supercentenarians who have been autopsied.FAP can be ameliorated by liver transplantation.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles